HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B

Farag M., Campenhout M. V., van Boemmel F., Rijckborst V., Cakaloglu Y., Ferenci P., ...More

International Liver Congress (ILC), Paris, France, 11 - 15 April 2018, vol.68 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 68
  • Doi Number: 10.1016/s0168-8278(18)31269-8
  • City: Paris
  • Country: France
  • Istanbul University Affiliated: Yes